These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20613495)

  • 1. SSR504734, a glycine transporter-1 inhibitor, attenuates acquisition and expression of contextual conditioned fear in rats.
    Nishikawa H; Inoue T; Izumi T; Nakagawa S; Koyama T
    Behav Pharmacol; 2010 Sep; 21(5-6):576-9. PubMed ID: 20613495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of MS-153 on the acquisition and expression of conditioned fear in rats.
    Li X; Inouei T; Abekawai T; YiRui F; Koyama T
    Eur J Pharmacol; 2004 Nov; 505(1-3):145-9. PubMed ID: 15556147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158.
    Tsutsumi T; Akiyoshi J; Isogawa K; Kohno Y; Hikichi T; Nagayama H
    Neuropeptides; 1999 Dec; 33(6):483-6. PubMed ID: 10657528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycine transporter-1 reduces cue-induced nicotine-seeking, but does not promote extinction of conditioned nicotine cue responding in the rat.
    Cervo L; Di Clemente A; Orrù A; Moro F; Cassina C; Pich EM; Corsi M; Gozzi A; Bifone A
    Addict Biol; 2013 Sep; 18(5):800-11. PubMed ID: 23490434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
    Leonetti M; Desvignes C; Bougault I; Souilhac J; Oury-Donat F; Steinberg R
    Neuroscience; 2006; 137(2):555-64. PubMed ID: 16289893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear.
    Inoue T; Izumi T; Li XB; Kitaichi Y; Nakagawa S; Koyama T
    Eur J Pharmacol; 2005 Sep; 519(3):253-8. PubMed ID: 16135362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
    Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158].
    Tsutsumi T; Isogawa K; Kouno Y; Hikichi T; Nagayama H; Akiyoshi J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Feb; 18(1):15-8. PubMed ID: 9592807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single prolonged stress increases contextual freezing and the expression of glycine transporter 1 and vesicle-associated membrane protein 2 mRNA in the hippocampus of rats.
    Iwamoto Y; Morinobu S; Takahashi T; Yamawaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):642-51. PubMed ID: 17267088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety].
    Izumi T
    Hokkaido Igaku Zasshi; 1998 Sep; 73(5):463-73. PubMed ID: 9846276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of fear extinction by infusion of glycine transporter blockers into the amygdala.
    Mao SC; Lin HC; Gean PW
    Mol Pharmacol; 2009 Aug; 76(2):369-78. PubMed ID: 19411609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior chronic nicotine impairs cued fear extinction but enhances contextual fear conditioning in rats.
    Tian S; Gao J; Han L; Fu J; Li C; Li Z
    Neuroscience; 2008 Jun; 153(4):935-43. PubMed ID: 18440720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between the glycine transporter 1(GlyT1) inhibitor SSR504734 and psychoactive drugs in mouse motor behaviour.
    Singer P; Feldon J; Yee BK
    Eur Neuropsychopharmacol; 2009 Aug; 19(8):571-80. PubMed ID: 19282154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of conditioned fear stress on monoaminergic systems in the rat brain].
    Inoue T
    Hokkaido Igaku Zasshi; 1993 May; 68(3):377-90. PubMed ID: 7686527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.
    Hikichi T; Akiyoshi J; Yamamoto Y; Tsutsumi T; Isogawa K; Nagayama H
    Pharmacopsychiatry; 2000 Sep; 33(5):189-93. PubMed ID: 11071021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inactivation of serotonergic neurons of the median raphe nucleus on learning and performance of contextual fear conditioning.
    Borelli KG; Gárgaro AC; dos Santos JM; Brandão ML
    Neurosci Lett; 2005 Oct; 387(2):105-10. PubMed ID: 16085359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear.
    Nishikawa H; Inoue T; Masui T; Izumi T; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):926-31. PubMed ID: 17376576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the hippocampal glycinergic system in an animal model of posttraumatic stress disorder.
    Yamamoto S; Morinobu S; Iwamoto Y; Ueda Y; Takei S; Fujita Y; Yamawaki S
    J Psychiatr Res; 2010 Nov; 44(15):1069-74. PubMed ID: 20427053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning.
    Pugh CR; Kumagawa K; Fleshner M; Watkins LR; Maier SF; Rudy JW
    Brain Behav Immun; 1998 Sep; 12(3):212-29. PubMed ID: 9769157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.